Delivery Order SPE2DE24D0013-SPE2D626F90G7
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $5,775.00 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The delivery order, designated XPRS-COV2-10, is expected to be completed by November 20, 2025, and carries no set-aside designation. This award represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $1,694 firm fixed-price delivery order (Contract No. XPRS-COV2-10) by the Defense Logistics Agency Medical Supply Chain on January 7, 2026. The delivery order, with an ultimate completion date of January 14, 2026, is issued under Cepheid's existing Indefinite Delivery Contract with the Veterans Health Administration VISN 17, valued at $6.7 million through December 28, 2029. The award carries...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570331464 | XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 29, 2025. This delivery order, which carries no set-aside designation, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17, valued at $6.7...
- Cepheid Inc. was awarded a firm fixed-price delivery order valued at $16,320 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. The delivery order, designated 4570410037 XPRS4PLEX-10, represents work performed at Cepheid's headquarters in Sunnyvale, California, and carries no set-aside designation. This award falls under Cepheid's existing Indefinite Delivery Contract framework with the Department of Veterans Affairs'...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 firm fixed-price delivery order (Contract No. 4570311585, XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Contract (IDC) established with the Department of Veterans Affairs VISN 17, valued at $6.7 million through December...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 on January 7, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 14, 2026, and falls under Cepheid's existing Indefinite Delivery Contract with the Veterans Integrated Service Network 6 valued at $32.8M through September 30, 2030. No...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,182.80 firm fixed-price delivery order (XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on November 25, 2025, with an ultimate completion date of December 3, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's substantial role as a federal supplier of molecular diagnostic solutions. The award is associated with Cepheid's broader Indefinite Delivery Contracts...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F90G7Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7 million and extends through December 28, 2029. The delivery order calls for XPRS4PLEX-10 cartridges and related diagnostic testing supplies designed for Cepheid's GeneXpert diagnostic platform, supporting the federal healthcare system's infectious disease testing and clinical laboratory operations. The contract contains no set-aside designation and utilizes a firm fixed-price structure. This award reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across the Department of Veterans Affairs and multiple federal healthcare agencies. The company has demonstrated extensive capability in providing rapid diagnostic testing for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases through its GeneXpert platform and associated reagents. Cepheid maintains additional substantial IDV vehicles with the VA, including a $32.8 million contract with VISN 6 extending through September 2030, underscoring the department's reliance on Cepheid's diagnostic capabilities to support clinical operations across the distributed network of VA medical centers and integrated service networks nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 1/6/26 |